muc5ac elisa kit (Elabscience Biotechnology)
Elabscience Biotechnology is a verified supplier 
Elabscience Biotechnology manufactures this product 
93
Structured Review
Elabscience Biotechnology
muc5ac elisa kit
Muc5ac Elisa Kit, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 19 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+muc5ac+elisa+kit/Human+MUC5AC+(Mucin+5+Subtype+AC)+ELISA+Kit/pm41418940-96-18-22
Average 93 stars, based on 19 article reviews
Muc5ac Elisa Kit, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 19 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+muc5ac+elisa+kit/Human+MUC5AC+(Mucin+5+Subtype+AC)+ELISA+Kit/pm41418940-96-18-22
Average 93 stars, based on 19 article reviews
muc5ac elisa kit - by Bioz Stars,
2026-09
93/100 stars
Images
Related Articles
Enzyme-linked Immunosorbent Assay:Article Title: Evaluation of mucin changes between daily and extended wear silicone hydrogel contact lenses Article Snippet: .. Mucin 5AC examination was performed at pre-fitting and at the 4th week using a Article Title: In vivo and in vitro investigation of anti-inflammatory and mucus-regulatory activities of a fixed combination of thyme and primula extracts. Article Snippet: Accepted Manuscript In vivo and in vitro investigation of anti-inflammatory and mucus-regulatory activities of a fixed combination of thyme and primula extracts Jan Seibel, Kirill Kryshen, Judit E. Pongrácz, Martin D. Lehner PII: S1094-5539(18)30060-9 DOI: 10.1016/j.pupt.2018.04.009 Reference: YPUPT 1727 To appear in: Pulmonary Pharmacology & Therapeutics Received Date: 7 March 2018 Revised Date: 20 April 2018 Accepted Date: 21 April 2018 Please cite this article as: Seibel J, Kryshen K, Pongrácz JE, Lehner MD, In vivo and in vitro investigation of anti-inflammatory and mucus-regulatory activities of a fixed combination of thyme and primula extracts, Pulmonary Pharmacology & Therapeutics (2018), doi: 10.1016/j.pupt.2018.04.009.. This is a PDF file of an unedited manuscript that has been accepted for publication.. As a service to our customers we are providing this early version of the manuscript. Article Title: Identification of a serum biomarker panel for the differential diagnosis of cholangiocarcinoma and primary sclerosing cholangitis Article Snippet: Standard blood tests including liver biochemistry (total bilirubin (TBIL), alkaline phosphatase (ALP), gamma-glutamyl transferase (GGT)), C-reactive protein (CRP) and CA19-9 (Cobas CA19-9 CLIA; Roche and Fujirebio Diagnostics) were carried out at the Clinical Biochemistry service of UCLH. .. Samples were evaluated for the other candidate biomarkers using the following commercial ELISA kits at the dilutions specified and with the indicated intra-assay CVs: human LRG1 ELISA kit (IBL International, Hamburg, Germany; 1:2000; CV = 5.5%), human IL-6 ELISA Kit (Pierce Biotechnology, Rockford, IL, USA; 1:5; CV = 6.7%), human PKM2 ELISA kit (Cloud-Clone Corp. Wuhan, China; 1:10; CV = 10.3%), human cytokeratin fragment antigen 21-1 (CYFRA21.1) ELISA Kit (Cusabio, Wuhan, China; 1:5; CV = 8.1%) and Intra Assay:Article Title: Identification of a serum biomarker panel for the differential diagnosis of cholangiocarcinoma and primary sclerosing cholangitis Article Snippet: Standard blood tests including liver biochemistry (total bilirubin (TBIL), alkaline phosphatase (ALP), gamma-glutamyl transferase (GGT)), C-reactive protein (CRP) and CA19-9 (Cobas CA19-9 CLIA; Roche and Fujirebio Diagnostics) were carried out at the Clinical Biochemistry service of UCLH. .. Samples were evaluated for the other candidate biomarkers using the following commercial ELISA kits at the dilutions specified and with the indicated intra-assay CVs: human LRG1 ELISA kit (IBL International, Hamburg, Germany; 1:2000; CV = 5.5%), human IL-6 ELISA Kit (Pierce Biotechnology, Rockford, IL, USA; 1:5; CV = 6.7%), human PKM2 ELISA kit (Cloud-Clone Corp. Wuhan, China; 1:10; CV = 10.3%), human cytokeratin fragment antigen 21-1 (CYFRA21.1) ELISA Kit (Cusabio, Wuhan, China; 1:5; CV = 8.1%) and |
